{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-026051","form_type":"8-K","ticker":"PVLA","cik":"0001583648","company_name":"PALVELLA THERAPEUTICS, INC.","filed_at":"2022-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.280416+00:00","generated_at":"2026-06-22T06:56:14.163829+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pieris Pharmaceuticals increases ATM offering capacity to $75M under amended Jefferies agreement","bullets":["As of Nov 4, 2022, Pieris had sold $33.6M of stock under the prior $50M ATM program.","Amendment raises aggregate offering amount to $75M, exclusive of shares previously sold.","Jefferies will use commercially reasonable efforts for at-the-market sales on Nasdaq.","Company is not obligated to sell any shares; other terms of the Sales Agreement unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-026051","json":"https://secwatch.observer/filing/0001437749-22-026051.json","markdown":"https://secwatch.observer/filing/0001437749-22-026051.md","text":"https://secwatch.observer/filing/0001437749-22-026051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583648/000143774922026051/0001437749-22-026051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583648/000143774922026051/pirs20221103_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T06:56:14.163829+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}